Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S John

Showing results (1061-1070 of 1,133) with videos related to

Pageof 114
Sort By:
British Journal of Sports Medicine|April 28, 2017
The Concussion Recognition Tool 5th Edition (CRT5): Background and rationaleRuben J Echemendia, Willem Meeuwisse, Paul McCrory, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2025
Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 TrialJung-Min Lee, Austin Miller, Peter G Rose, et al.
Journal of Neurosurgery|January 21, 2022
Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumorsWilliam C Chen, Matthieu Lafreniere, Christina Phuong, et al.
Scientific Reports|August 3, 2019
Prospective Validation of an Ex Vivo, Patient-Derived 3D Spheroid Model for Response Predictions in Newly Diagnosed Ovarian CancerStephen Shuford, Christine Wilhelm, Melissa Rayner, et al.
Research Square|June 12, 2026
DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell typesDavid Raleigh, S John Liu, Nazanin Majd, et al.
JCI Insight|September 23, 2025
Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastomaSixuan Pan, Kanish Mirchia, Emily Payne, et al.
Theranostics|February 28, 2020
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancerBrittney S Harrington, Yaowu He, Tashbib Khan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 9, 2019
Respiratory health status is associated with treatment outcomes in pulmonary tuberculosisA N Gupte, S Selvaraju, M Paradkar, et al.
JAMA Network Open|October 16, 2024
Patient-Reported Outcomes Among Adults With Congenital Heart Disease in the Congenital Heart Initiative RegistryScott Leezer, Rittal Mehta, Anushree Agarwal, et al.
Molecular Cancer|October 7, 2024
Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitorsAnnapoorna Venkatachalam, Cristina Correia, Kevin L Peterson, et al.
Pageof 114

Showing results (1061-1070 of 1,133) with videos related to

Sort By:
Pageof 114
British Journal of Sports Medicine|April 28, 2017
The Concussion Recognition Tool 5th Edition (CRT5): Background and rationaleRuben J Echemendia, Willem Meeuwisse, Paul McCrory, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2025
Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 TrialJung-Min Lee, Austin Miller, Peter G Rose, et al.
Journal of Neurosurgery|January 21, 2022
Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumorsWilliam C Chen, Matthieu Lafreniere, Christina Phuong, et al.
Scientific Reports|August 3, 2019
Prospective Validation of an Ex Vivo, Patient-Derived 3D Spheroid Model for Response Predictions in Newly Diagnosed Ovarian CancerStephen Shuford, Christine Wilhelm, Melissa Rayner, et al.
Research Square|June 12, 2026
DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell typesDavid Raleigh, S John Liu, Nazanin Majd, et al.
JCI Insight|September 23, 2025
Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastomaSixuan Pan, Kanish Mirchia, Emily Payne, et al.
Theranostics|February 28, 2020
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancerBrittney S Harrington, Yaowu He, Tashbib Khan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 9, 2019
Respiratory health status is associated with treatment outcomes in pulmonary tuberculosisA N Gupte, S Selvaraju, M Paradkar, et al.
JAMA Network Open|October 16, 2024
Patient-Reported Outcomes Among Adults With Congenital Heart Disease in the Congenital Heart Initiative RegistryScott Leezer, Rittal Mehta, Anushree Agarwal, et al.
Molecular Cancer|October 7, 2024
Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitorsAnnapoorna Venkatachalam, Cristina Correia, Kevin L Peterson, et al.
Pageof 114